Antheia Overview

  • Founded
  • 2013
Founded
  • Status
  • Private
  • Employees
  • 32
Employees
  • Latest Deal Type
  • Series B
  • Latest Deal Amount
  • $73M
Latest Deal Amount
  • Investors
  • 13

Antheia General Information

Description

Developer of plant-inspired medicines created to tap the full potential of nature to discover new medicines. The company's cost-competitive, plant-based medicines are made using synthetic biology, informatics and fermentation technology to harness beneficial molecules from plants to create active pharmaceutical ingredients, thus enabling healthcare organizations to provide patients with natural and healthier medication.

Contact Information

Website
www.antheia.bio
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Pharmaceuticals
Primary Office
  • 1430 O'Brien Drive
  • Suite A
  • Menlo Park, CA 94025
  • United States
+1 (650) 000-0000

Antheia Timeline

2018201920202021
Financing RoundFinancing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Antheia Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Later Stage VC (Series B) 30-Jun-2021 $73M 000.00 00000 Completed Product Development
9. Debt - PPP 13-Apr-2020 00000 000.00 Completed Product Development
8. Later Stage VC 01-Jan-2020 000.00 Completed Product Development
7. Debt - General 31-Dec-2019 00.000 000.00 Completed Product Development
6. Later Stage VC (Series B) 04-Sep-2018 00.00 000.00 00000 Completed Product Development
5. Grant 01-Jan-2018 00000 00.00 Completed Startup
4. Early Stage VC (Series A) 26-May-2017 00.000 00.00 00000 Completed Startup
3. Grant 01-Jan-2017 00000 00.000 Completed Startup
2. Seed Round 13-Mar-2015 $1.97M $1.97M 00.000 Completed Startup
1. Accelerator/Incubator Completed Startup
To view Antheia’s complete valuation and funding history, request access »

Antheia Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B-3 0,000,000 00.000000 00.0 00.00 00.00 00 00.00 00.000
Series B-2 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 0.000
Series B-1 000,000 00.000000 00.00 00.00 00.00 00 00.00 0.000
Series A 6,880,436 $0.000100 $0.71 $8.89 $8.89 1x $8.6 23.35%
Seed 2,237,536 $0.000100 $0.09 $1.12 $1.12 1x $1.12 7.35%
To view Antheia’s complete cap table history, request access »

Antheia Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of plant-inspired medicines created to tap the full potential of nature to discover new medicines. The company
Drug Discovery
Menlo Park, CA
32 As of 2021
000.00
0000 0000-00-00
00000000000 000.00

000000 0

00000 0000000000 0000000000 0000000
Boston, MA
000 As of 0000
00.000
000000000 00.000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Antheia Competitors (1)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
000000 00000000 00 Formerly VC-backed Boston, MA 000 00.000 000000000 00.000
You’re viewing 1 of 1 competitors. Get the full list »

Antheia Executive Team (6)

Name Title Board Seat Contact Info
Christina Smolke Ph.D Co-Founder, Chief Executive Officer & Board Member
Kristy Hawkins Ph.D Co-Founder, Chief Scientific Officer & Board Member
Yen-Hsiang Wang Head of Strategy and BD
You’re viewing 3 of 6 executive team members. Get the full list »

Antheia Board Members (4)

Name Representing Role Since
Christina Smolke Ph.D Antheia Co-Founder, Chief Executive Officer & Board Member 000 0000
Kristy Hawkins Ph.D Antheia Co-Founder, Chief Scientific Officer & Board Member 000 0000
Patrick Yang Ph.D Antheia Board Member 000 0000
Ram Shriram Self Board Member 000 0000
To view Antheia’s complete board members history, request access »

Antheia Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Antheia Investors (13)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Hillspire Corporation Minority 000 0000 000000 0
Viking Global Investors Hedge Fund Minority 000 0000 000000 0
Civilization Ventures Venture Capital Minority 000 0000 000000 0
Codon Capital Venture Capital Minority 000 0000 000000 0
Karl Handelsman Angel (individual) Minority 000 0000 000000 0
You’re viewing 5 of 13 investors. Get the full list »